Efficacy of low-dose landiolol, an ultrashort-acting β-blocker, on postoperative atrial fibrillation in patients undergoing pulmonary resection for lung cancer-Reference-Cited by-同舟云学术

Efficacy of low-dose landiolol, an ultrashort-acting β-blocker, on postoperative atrial fibrillation in patients undergoing pulmonary resection for lung cancer

Published:2011-12 Issue:12 Volume:59 Page:799-805
ISSN:1863-6705
Container-title:General Thoracic and Cardiovascular Surgery
language:en
Short-container-title:Gen Thorac Cardiovasc Surg

Author:

Nojiri Takashi,Yamamoto Kazuhiro,Maeda Hajime,Takeuchi Yukiyasu,Funakoshi Yasunobu,Maekura Ryoji,Okumura Meinoshin

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s11748-011-0841-x.pdf

Reference22 articles.

1. Cardinale D, Martinoni A, Cipolla CM, Civelli M, Lamantia G, Fiorentini C, et al. Atrial fibrillation after operation for lung cancer: clinical and prognostic significance. Ann Thorac Surg 1999;68:1827–1831.

2. Roselli EE, Murthy SC, Rice TW, Houghtaling PL, Pierce CD, Karchmer DP, et al. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg 2005;130:438–444.

3. Amar D, Roistacher N, Burt M, Reinsel RA, Ginsberg RJ, Wilson RS. Clinical and echocardiographic correlates of symptomatic tachydysrhythmias after noncardiac thoracic surgery. Chest 1995;108:349–354.

4. Vaporciyan AA, Correa AM, Rice DC, Roth JA, Smythe WR, Swisher SG, et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg 2004;127:779–786.

5. Amar D. Postoperative atrial fibrillation. Heart Dis 2002;4: 117–123.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Landiolol for perioperative atrial tachyarrhythmias in cardiac and thoracic surgery patients: a systematic review and meta-analysis;British Journal of Anaesthesia;2024-07

2. Landiolol for Treatment of New-Onset Atrial Fibrillation in Critical Care: A Systematic Review;Journal of Clinical Medicine;2024-05-17

3. An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation;Pharmaceutics;2024-04-08

4. A landiolol alkalmazási lehetőségei a kardiológiai és intenzív terápiás ellátásban;Orvosi Hetilap;2022-01-09

5. Dose-dependent scavenging activity of the ultra-short-acting β1-blocker landiolol against specific free radicals;Journal of Clinical Biochemistry and Nutrition;2022